Code intelligence

LCD-L40242 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code LCD-L40242.

Critical code risk

Signal breakdown

1 shown · 1 total in platform

Risk: Critical

Critical

100%

High

Routine

Low

New this month

alerts added in last 30 days

Effective soon

—

no upcoming deadlines

LCD L40242: MolDX: Genetic Testing for Hereditary Thrombophilia — Noridian

Policy LCD-L40242 · Clinical Laboratory

Critical

This final LCD from Noridian (Jurisdictions E and F) establishes coverage criteria for MolDX genetic testing for hereditary thrombophilia, effective October 12, 2026, across 15 Western and Mountain st

View alert

Audit documentation

Building an audit file that includes LCD-L40242?

The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription